Functional and Molecular Characterization of New SPTLC1 Missense Variants in Patients with Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1)
Genes · 2024
DOI: 10.3390/genes15060692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Julie Rochat und 13 weiteren Autor:innen. Beteiligte Einrichtung: Unité Pathologies Métaboliques, Érythrocytaires et Dépistage Périnatal, Service de Biochimie et Biologie Moléculaire, Centre de Biologie et de Pathol…. Hauptthemen laut MEDLINE: Serine C-Palmitoyltransferase, Hereditary Sensory and Autonomic Neuropathies, Mutation, Missense, Sphingolipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Multidisciplinary Digital Publishing Institute (Switzerland).
Abstract (Originalsprache)
Hereditary sensory and autonomic neuropathy type 1 is an autosomal dominant neuropathy caused by the SPTLC1 or SPTLC2 variants. These variants modify the preferred substrate of serine palmitoyl transferase, responsible for the first step of de novo sphingolipids synthesis, leading to accumulation of cytotoxic deoxysphingolipids. Diagnosis of HSAN1 is based on clinical symptoms, mainly progressive loss of distal sensory keep, and genetic analysis.
Aim
Identifying new SPTLC1 or SPTLC2 “gain-of-function” variants raises the question as to their pathogenicity. This work focused on characterizing six new SPTLC1 variants using in silico prediction tools, new meta-scores, 3D modeling, and functional testing to establish their pathogenicity.
Methods
Variants from six patients with HSAN1 were studied. In silico, CADD and REVEL scores and the 3D modeling software MITZLI were used to characterize the pathogenic effect of the variants. Functional tests based on plasma sphingolipids quantification (total deoxysphinganine, ceramides, and dihydroceramides) were performed by tandem mass spectrometry.
Results
In silico predictors did not provide very contrasting results when functional tests discriminated the different variants according to their impact on deoxysphinganine level or canonical sphingolipids synthesis. Two SPTLC1 variants were newly described as pathogenic: SPTLC1 NM_006415.4:c.998A>G and NM_006415.4:c.1015G>A.
Discussion
The combination of the different tools provides arguments to establish the pathogenicity of these new variants. When available, functional testing remains the best option to establish the in vivo impact of a variant. Moreover, the comprehension of metabolic dysregulation offers opportunities to develop new therapeutic strategies for these genetic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unité Pathologies Métaboliques, Érythrocytaires et Dépistage Périnatal, Service de Biochimie et Biologie Moléculaire, Centre de Biologie et de Pathologie Est, Hospices Civils de Lyon, 69500 Bron, France.
- Biokerden, 76130 Mont Saint-Aignan, France.
- Service Système Nerveux Périphérique et Muscle, Université Côte d'Azur, Centre Hospitalier Universitaire Nice, 06000 Nice, France.
- Centre de Référence des Maladies Neuromusculaires de l'Enfant, Hôpital Timone Enfants, Assistance Publique Hôpitaux de Marseille 13915 Marseille, France.
- Service de Neurologie et Unité Neuro-Vasculaire, Centre Hospitalier de Valence, 26953 Valence, France.
- Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique Hôpitaux de Marseille, 13915 Marseille, France.
ORCID-Profile: André Blavier, Isabelle Quadrio, Nathalie Bonello-Palot, David Cheillan
Förderung
- Multidisciplinary Digital Publishing Institute (Switzerland)
Zitieren
APA
Rochat, J., Blavier, A., Ruet, S., Vasseur, S., Puma, A., Desnous, B., Chan, V., Delmont, E., Attarian, S., Juntas Morales, R., Quadrio, I., Vidoni, L., Bonello-Palot, N., & Cheillan, D. (2024). Functional and Molecular Characterization of New SPTLC1 Missense Variants in Patients with Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1). Genes. https://doi.org/10.3390/genes15060692
Vancouver
Rochat J, Blavier A, Ruet S, Vasseur S, Puma A, Desnous B, et al. Functional and Molecular Characterization of New SPTLC1 Missense Variants in Patients with Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1). Genes. 2024. doi:10.3390/genes15060692
BibTeX
@article{Rochat2024,
author = {Rochat, Julie and Blavier, André and Ruet, Séverine and Vasseur, Sophie and Puma, Angela and Desnous, Béatrice and Chan, Victor and Delmont, Emilien and Attarian, Shahram and Juntas Morales, Raul and Quadrio, Isabelle and Vidoni, Léo and Bonello-Palot, Nathalie and Cheillan, David},
title = {Functional and Molecular Characterization of New SPTLC1 Missense Variants in Patients with Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1)},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15060692}
}
EUVIMED